Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists explored the feasibility of generating bivalent-Leuk-STs directed against Wilms tumor 1 and preferentially expressed antigen in melanoma from umbilical cord blood units disqualified for allogeneic hematopoietic stem cell transplantation.
[British Journal of Haematology]
6445218 ZHBHNHZ7 items 1 apa 0 default asc 1 162918 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-1f48115f91402a891632c8573d66ab93%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZHBHNHZ7%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Koukoulias%20et%20al.%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKoukoulias%2C%20K.%2C%20Papadopoulou%2C%20A.%2C%20Kouimtzidis%2C%20A.%2C%20Papayanni%2C%20P.-G.%2C%20Papaloizou%2C%20A.%2C%20Sotiropoulos%2C%20D.%2C%20Yiangou%2C%20M.%2C%20Costeas%2C%20P.%2C%20Anagnostopoulos%2C%20A.%2C%20Yannaki%2C%20E.%2C%20%26amp%3B%20Kaloyannidis%2C%20P.%20%28n.d.%29.%20Non-transplantable%20cord%20blood%20units%20as%20a%20source%20for%20adoptive%20immunotherapy%20of%20leukaemia%20and%20a%20paradigm%20of%20circular%20economy%20in%20medicine.%20%3Ci%3EBritish%20Journal%20of%20Haematology%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2Fhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fbjh.17464%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2Fhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fbjh.17464%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DZHBHNHZ7%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Non-transplantable%20cord%20blood%20units%20as%20a%20source%20for%20adoptive%20immunotherapy%20of%20leukaemia%20and%20a%20paradigm%20of%20circular%20economy%20in%20medicine%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiriakos%22%2C%22lastName%22%3A%22Koukoulias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anastasia%22%2C%22lastName%22%3A%22Papadopoulou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anastasios%22%2C%22lastName%22%3A%22Kouimtzidis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Penelope-Georgia%22%2C%22lastName%22%3A%22Papayanni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andri%22%2C%22lastName%22%3A%22Papaloizou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damianos%22%2C%22lastName%22%3A%22Sotiropoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minas%22%2C%22lastName%22%3A%22Yiangou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Costeas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Achilles%22%2C%22lastName%22%3A%22Anagnostopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evangelia%22%2C%22lastName%22%3A%22Yannaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Panayotis%22%2C%22lastName%22%3A%22Kaloyannidis%22%7D%5D%2C%22abstractNote%22%3A%22Advances%20in%20immunotherapy%20with%20T%20cells%20armed%20with%20chimeric%20antigen%20receptors%20%28CAR-Ts%29%2C%20opened%20up%20new%20horizons%20for%20the%20treatment%20of%20B-cell%20lymphoid%20malignancies.%20However%2C%20the%20lack%20of%20appropriate%20targetable%20antigens%20on%20the%20malignant%20myeloid%20cell%20deprives%20patients%20with%20refractory%20acute%20myeloid%20leukaemia%20of%20effective%20CAR-T%20therapies.%20Although%20non-engineered%20T%20cells%20targeting%20multiple%20leukaemia-associated%20antigens%20%5Bi.e.%20leukaemia-specific%20T%20cells%20%28Leuk-STs%29%5D%20represent%20an%20alternative%20approach%2C%20the%20prerequisite%20challenge%20to%20obtain%20high%20numbers%20of%20dendritic%20cells%20%28DCs%29%20for%20large-scale%20Leuk-ST%20generation%2C%20limits%20their%20clinical%20implementation.%20We%20explored%20the%20feasibility%20of%20generating%20bivalent-Leuk-STs%20directed%20against%20Wilms%20tumour%201%20%28WT1%29%20and%20preferentially%20expressed%20antigen%20in%20melanoma%20%28PRAME%29%20from%20umbilical%20cord%20blood%20units%20%28UCBUs%29%20disqualified%20for%20allogeneic%20haematopoietic%20stem%20cell%20transplantation.%20By%20repurposing%20non-transplantable%20UCBUs%20and%20optimising%20culture%20conditions%2C%20we%20consistently%20produced%20at%20clinical%20scale%2C%20both%20cluster%20of%20differentiation%20%28CD%2934%2B%20cell-derived%20myeloid%20DCs%20and%20subsequently%20polyclonal%20bivalent-Leuk-STs.%20Those%20bivalent-Leuk-STs%20contained%20CD8%2B%20and%20CD4%2B%20T%20cell%20subsets%20predominantly%20of%20effector%20memory%20phenotype%20and%20presented%20high%20specificity%20and%20cytotoxicity%20against%20both%20WT1%20and%20PRAME.%20In%20the%20present%20study%2C%20we%20provide%20a%20paradigm%20of%20circular%20economy%20by%20repurposing%20unusable%20UCBUs%20and%20a%20platform%20for%20future%20banking%20of%20Leuk-STs%2C%20as%20a%20%5Cu2018third-party%5Cu2019%2C%20%5Cu2018off-the-shelf%5Cu2019%20T-cell%20product%20for%20the%20treatment%20of%20acute%20leukaemias.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fbjh.17464%22%2C%22ISSN%22%3A%221365-2141%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1111%5C%2Fbjh.17464%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-02T17%3A31%3A41Z%22%7D%7D%5D%7D
Koukoulias, K., Papadopoulou, A., Kouimtzidis, A., Papayanni, P.-G., Papaloizou, A., Sotiropoulos, D., Yiangou, M., Costeas, P., Anagnostopoulos, A., Yannaki, E., & Kaloyannidis, P. (n.d.). Non-transplantable cord blood units as a source for adoptive immunotherapy of leukaemia and a paradigm of circular economy in medicine. British Journal of Haematology, n/a(n/a). https://doi.org/https://doi.org/10.1111/bjh.17464 Cite
